Studies on the Mechanism and Epidemiology of Mother-To-Child HTLV-I Transmission by the Use of PCR (Polymerase Chain Reaction) Method.
Studies on the Mechanism and Epidemiology of Mother-To-Child HTLV-I Transmission by the Use of PCR (Polymerase Chain Reaction) Method.
批准号:
03807016
负责人:
TAKEI Hiroshi
金额:
$1.15万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1993
中文摘要
点击翻译按钮获取中文摘要
英文摘要
These studies aim at investigating what is the true mechanism of mother-to-child HTLV-I transmission and real feature of the epidemiology and establishing preventive measures against mother-to-child transmission and the best feeding for the infants. The results are as follows :1. A method for detecting proviral DNA in the lymphocytes of colostrum from HTLV-I carriers with the PCR was developed, by which proviral DNA in the peripheral lymphocytes from carriers could also be detected and semi-quantitative assay for provirus copy number was established.2. A rapid and simplified method for purifying DNA from whole blood was established.3. The seroprevalence of HTLV-I in children born to carrier-mothers was surveyed from the blood sample of different feeding group. As a results, the seroprevalence in a normal breast feeding group was 6.1%, 7.7% in a group fed with freez-thawed breast milk and none in a bottle-fed group. The copy number of the HTLV-I provirus in the peripheral lymphocytes of … More the carrier-mothers was most correlated to the seroconversion of the infants who received breast milk from them. From this result, the semi-quantitative assay fro provirus copy number mentioned above, was modified and a quantitative assay was established. P40^<tax> antibody-positivity of the carrier-mothers was relevant to the seroconversion rate in children, which was not significant statistically.4. The difference between the seroconversion rate for the normal breast feeding group and others was statistically insignificant.5. The overall prevalence of HTLV-I antibodies in pregnant women was 6.5% in Okinawa. The antibody-positive rate was significantly higher in multiparous patients than in primiparous patients(p < 0.05). From the results above, the seroconversion rate for the normal breast feeding group was relatively low compared to the reports by other investigators, which cast some doubt on the policy for totally stopping the breast feeding. The copy number of the HTLV-I provirus in the peripheral lymphocytes of the carrier mothers was most correlated to the seroconversion of the infants who received breast milk from them, which can be a useful index for the mother-to-child transmission. Less
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
前濱俊之: "HTLV-I母児感染の実態及び児のキャリア化に関する因子" 医学のあゆみ. 168. 262-263 (1994)
Toshiyuki Maehama:“HTLV-I 母婴感染的实际状况以及与婴儿携带者状况相关的因素”,《医学史》168. 262-263 (1994)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
前濱 俊之: "沖縄におけるHTLV-Iキャリア妊婦の実態とWest-ern blot法によるIgM抗体の解析および児のキャリア化について" 琉球医学会誌. 12. 262-269 (1992)
Toshiyuki Maehama:“冲绳HTLV-I携带者孕妇的实际情况、通过蛋白质印迹法分析IgM抗体以及携带者婴儿的发育”《琉球医学会杂志》12. 262-269 (1992)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
前濱 俊之: "HTLVーI母児感染におけるキャリア母の児のキャリア化におよぼす因子について" 日本産科婦人科学会雑誌. 44. 215-222 (1992)
Toshiyuki Maehama:“HTLV-I 母婴感染中携带者母亲子女发育的影响因素”日本妇产科学会杂志 44. 215-222 (1992)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Maehama et al.: "A Quantative Assay for Provirus DNA of HTLV-I Carrier-Mothers and Carrier-Infants in Mother-To-Child Transmission and its Implication." Acta Obst.Gynaec.Jpn.45(suppl). 340 (1993)
T.Maehama 等人:“母婴传播中 HTLV-I 携带者母亲和携带者婴儿原病毒 DNA 的定量分析及其影响”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Maehama et al.: "The Real Feature of HTLV-I Mother-To-Child Transmission and Factors relevant to the seroconversion of the Children." Igaku-No-Ayumi. 168. 262-263 (1994)
T.Maehama 等人:“HTLV-I 母婴传播的真实特征以及与儿童血清转化相关的因素。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
Functional modulation and control of osteoclastgenesis by wear debris and inflammatory cytokines.
-
批准号:12671393
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:TAKEI Hiroshi
-
依托单位:
海外基金